二、董事会会议审议情况 （一）审议并通过了《关于公司未弥补亏损达到实收股本总额三分之一的议案》； 具体内容详见公司同日披露的《麦迪科技关于公司 2024 年度未弥补亏损达 到实收股本总额三分之一的公告》。 表决结果：同意 5 票；反对 0 票；弃权 0 票。 证券代码：603990 证券简称：麦迪科技 公告编号：2025-037 苏州麦迪斯顿医疗科技股份有限公司 第四届董事会第三十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"、"麦迪科技"）第 四届董事会第三十二次会议于 2025 年 6 月 13 日以通讯表决的方式召开。本次董 事会会议通知于 2025 年 6 月 12 日以邮件形式发出，经全体董事同意，豁免本次 董事会提前书面通知的要求。会议由董事长陈宁先生召集并主持，会议应出席董 事 5 名，实际出席董事 5 名，公司监事会成员及高级管理人员列席了本次会议。 会议召集及召开方式符合《中华人民共和国公司法》和《苏州麦迪斯顿医疗科 ...

Core Insights - The Shanghai International Elderly Care, Aids, and Rehabilitation Medical Expo showcases advancements in elderly care technology, with around 500 exhibitors from 16 countries [1][6] - The introduction of the "Xiao Mai" robot by Suzhou Meidi Technology is a highlight, designed specifically for elderly care scenarios, featuring capabilities such as visual recognition and voice interaction [3][5] Industry Overview - The aging population in China has surpassed 300 million, leading to a burgeoning silver economy projected to reach 30 trillion yuan, making "smart elderly care" a pressing social demand [6] - The establishment of Suzhou Youmai Robot Co., a joint venture between Meidi Technology and UBTECH, aims to focus on the development and industrialization of service robots in healthcare and elderly care [6] Product Features - "Xiao Mai" is a lightweight and agile robot, standing at 1.63 meters and weighing 43 kilograms, capable of performing various tasks such as greeting, health education, emotional interaction, and behavior monitoring [5][6] - The robot operates on a comprehensive solution that integrates a specialized AI model for elderly care with a smart management platform, facilitating data integration across healthcare systems and enhancing service delivery [6][8] Market Application - "Xiao Mai" is currently undergoing application testing in several elderly care institutions in Zhejiang and Shanghai, with plans to develop a smart elderly care solution characterized by platform-driven and model-enabled collaboration [8]

Core Viewpoint - The issuance of the "Notice" aims to accelerate the application and development of intelligent elderly care service robots in response to the increasing challenges of population aging through policy guidance and resource integration [3][4]. Summary by Relevant Sections Event - On June 9, 2025, the Ministry of Industry and Information Technology and the Ministry of Civil Affairs jointly released the "Notice on Conducting Pairing Attacks and Scene Application Pilot Work for Intelligent Elderly Care Service Robots" [2]. Main Content - The "Notice" emphasizes three main areas: 1. Establishing partnerships between enterprises and elderly care institutions to address five major needs, including disability care and emotional companionship, while overcoming shortcomings in safety and reliability. 2. Conducting scene application verification, requiring 200 households to validate home scenarios and deploying over 200 sets of equipment; for community/institution scenarios, covering more than 20 communities or elderly care institutions with at least 20 sets of equipment, with a verification period of no less than six months. 3. Improving standards and evaluation systems, requiring pilot units to jointly formulate standards for aging suitability and safety evaluation to enhance product reliability and intelligence [3][4]. Background - The aging process in China is deepening, with the population aged 60 and above expected to exceed 300 million by the end of 2024, accounting for 22% of the total population. There is a shortage of 5.5 million elderly care workers, particularly for disabled elderly care needs. The elderly care robot market has significant potential, but two core issues must be addressed: low public awareness and high product prices, along with insufficient intelligence [4]. - The silver economy is projected to reach approximately 7 trillion yuan in 2024, accounting for 6% of GDP, and is expected to grow to 30 trillion yuan by 2035, representing 10% of GDP. The domestic elderly care robot market is anticipated to exceed 30 billion yuan in 2024 and reach 50 billion yuan in 2025, with a compound annual growth rate of over 30% [4]. Investment Suggestions - The policy aims to bridge the gap between technology and commercialization, transitioning the elderly care robot industry from "concept innovation" to "scale application." The industry is recommended for attention, with specific stocks suggested for consideration [5][6].

Core Viewpoint - The recent policy announcement by the Ministry of Industry and Information Technology and the Ministry of Civil Affairs aims to promote the development of smart elderly care service robots, which is expected to significantly boost the industry and accelerate technology implementation and market penetration [1][2]. Industry Overview - China's aging population is accelerating, leading to a surge in demand for elderly care services, while resources remain scarce. The rapid development of AI technology presents new solutions for the elderly care industry, making the smart elderly care robot market a focal point [2]. - According to a report by Founder Securities, the market size of the smart elderly care robot industry is projected to reach approximately 7.9 billion yuan in 2024, with rehabilitation robots accounting for the largest share at 45%. Emotional companionship robots are expected to grow at a remarkable annual rate of 120%, with the market size potentially exceeding 50 billion yuan by 2025 [2]. Company Developments - Several listed companies are actively entering the smart elderly care robot sector. For instance, Xilong Health has indicated that smart rehabilitation assistive devices, including smart wheelchairs and exoskeleton robots, are key development areas, although no mature products have been launched yet [2]. - Ousheng Electric has gained a competitive edge with its new intelligent nursing robot, which can automatically sense and identify the status of disabled patients, significantly improving care efficiency and patient comfort [2]. - Medisdon Medical Technology has formed strategic partnerships to integrate medical information technology with elderly care robotics, aiming to create a comprehensive solution platform for smart elderly care [3]. Market Challenges - Despite the promising outlook for the smart elderly care robot industry, there are challenges such as the need for improved environmental perception and adaptability in complex settings, as well as high production costs due to expensive raw materials [5][6]. - The market is becoming increasingly competitive, with many companies entering the field, leading to potential homogenization of products. Some companies are rushing to launch products without mature technology, resulting in varying product quality [5][6]. - Companies must focus on continuous R&D investment, mastering core technologies, and optimizing cost control to succeed in this competitive landscape [6].

Company Overview - Madi Technology closed at 15.44 yuan, up 2.93%, with a latest price-to-book ratio of 5.75 and a total market capitalization of 4.729 billion yuan [1] - As of the first quarter of 2025, there is one institutional holder of Madi Technology, holding a total of 49.2201 million shares valued at 0.637 billion yuan [1] Business Operations - Suzhou Madi Technology Co., Ltd. specializes in providing Clinical Information System (CIS) application software and overall solutions for clinical information management [1] - The company's main products include self-developed software, comprehensive solutions, purchased software and hardware, operational and technical services, medical service income, and photovoltaic battery cells [1] Financial Performance - For the first quarter of 2025, Madi Technology reported operating revenue of 63.34 million yuan, a year-on-year decrease of 43.13% [1] - The net profit for the same period was 23.5959 million yuan, showing a year-on-year increase of 138.55% [1] - The sales gross margin stood at 66.10% [1] Industry Comparison - Madi Technology's price-to-earnings (P/E) ratio (TTM) is -17.79, while the industry average is 113.36 [2] - The industry median P/E ratio is 20.17, indicating that Madi Technology's valuation is significantly lower than the industry average [2] - The total market capitalization of Madi Technology is 4.729 billion yuan, compared to the industry average of 11.359 billion yuan [2]

截至2025年5月30日收盘，麦迪科技（603990）报收于14.96元，较上周的14.88元上涨0.54%。本周，麦 迪科技5月26日盘中最高价报15.85元。5月28日盘中最低价报14.67元。麦迪科技当前最新总市值45.82亿 元，在软件开发板块市值排名82/133，在两市A股市值排名3107/5146。 本周关注点 成熟解决方案上率先进行产品布局，并借助公司在医疗IT领域的技术基础，通过本体、场景、大模型的 协同构建整体解决方案平台。随着每一阶段机器人能力的迭代与场景的丰富，我们将持续推出契合市场 的新功能、新形态，推动康养机器人从"单点功能"走向"体系平台"。 问：光伏业务剥离后，公司2025年度净利润能否实现扭亏？传统医疗信息化业务有哪些新的增长点？ 答：公司2024年净利润亏损主要受光伏业务产业链价格下行影响，公司医疗信息化及医疗服务业务营收 稳定。公司已于2025年1月完成光伏业务的剥离，剥离后主营聚焦于医疗信息化和大健康领域，2025年 净利润将实现同比扭亏，财务结构更加清晰。公司医疗信息化传统业务保持稳健收入来源，同时在政策 推动下，未来，随着二级医院信息化建设、临床信息系统升级、区域协同 ...

Core Viewpoint - The company, Madi Technology, is focusing on the development of AI models tailored for medical scenarios, aiming to address specific issues in real clinical settings [2][4]. Group 1: AI and Medical Applications - Madi Technology's AI strategy will concentrate on high-frequency critical conditions and decision support, integrating models deeply with business systems [2]. - The company has a competitive advantage due to its extensive deployment of medical information systems and a large accumulation of structured data, enabling practical and continuously evolving medical AI models [2]. - The company is advancing a low-altitude drone AED solution, which is faster, denser, and more cost-effective than traditional deployment methods, significantly improving the accessibility and success rates of emergency responses [2]. Group 2: Robotics and Healthcare - The company's approach to rehabilitation robots starts with non-contact services, gradually expanding to semi-contact and more complex human-machine interactions [3]. - Madi Technology has extensive experience with hospital clients, providing a solid foundation for developing customized hardware and software solutions for various healthcare settings [3]. - The company has shifted its revenue structure to focus on high-value, high-margin medical services after divesting its solar business, enhancing its risk resilience and sustainable growth potential [3]. Group 3: Business Developments - Madi Technology's subsidiary, Haikou Mary Hospital, is the second private hospital in Hainan to obtain a reproductive medicine license, completing 1,306 egg retrieval cycles in 2024 with a revenue of 61.6 million yuan [3]. - The company plans to leverage the Hainan Free Trade Port policy to expand its core technologies and management practices into Southeast Asia and international markets [3]. Group 4: Corporate Governance - The company held its 2024 annual shareholders' meeting on May 20, 2025, where multiple resolutions were passed, including financial reports and plans for external financing [5].

北京市中伦（上海）律师事务所 关于苏州麦迪斯顿医疗科技股份有限公司 法律意见书 二〇二五年五月 法律意见书 北京市中伦（上海）律师事务所 关于苏州麦迪斯顿医疗科技股份有限公司 法律意见书 致：苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"） 北京市中伦（上海）律师事务所（以下简称"本所"）接受公司的委托，指 派律师出席并见证公司2024年年度股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 （以下简称"《股东会规则》"）、《律师事务所从事证券法律业务管理办法》 （以下简称"《证券法律业务管理办法》"）、《律师事务所证券法律业务执业 规则（试行）》（以下简称"《证券法律业务执业规则》"）等相关法律、行政 法规、规章、规范性文件及《苏州麦迪斯顿医疗科技股份有限公司章程》（以下 简称"《公司章程》"）的规定，就本次会议的召集与召开程序、召集人资格、 出席会议人员资格、会议表决程序及表决结果等事宜，出具本法律意见书。 对本法律意见书的出具，本所律师特作如下声明： 资格、会议表决程序及表决 ...

证券代码：603990 证券简称：麦迪科技 公告编号：2025-036 苏州麦迪斯顿医疗科技股份有限公司 2024年年度股东大会决议公告 | 1、出席会议的股东和代理人人数 | 263 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 71,761,487 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 23.7087 | (四)表决方式是否符合《公司法》及《公司章程》的规定，股东大会主持情况等。 本次股东大会由副董事长翁康先生主持，会议采用现场投票与网络投票相结合的 表决方式进行表决。本次会议的召集、召开符合《公司法》《公司章程》《公司股 东大会议事规则》等法律、法规和规范性文件的规定。 (五)公司董事和董事会秘书的出席情况 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 5 月 20 日 (二)股东大会召开的地点：江苏省苏州市工业园区归家巷 222 号麦迪科技会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 二、 议案审议情况 本公司董事会及全体 ...

北京市中伦（上海）律师事务所 关于苏州麦迪斯顿医疗科技股份有限公司 2024 年年度股东大会的 法律意见书 法律意见书 二〇二五年五月 北京市中伦（上海）律师事务所 关于苏州麦迪斯顿医疗科技股份有限公司 2024 年年度股东大会的 法律意见书 致：苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"） 北京市中伦（上海）律师事务所（以下简称"本所"）接受公司的委托，指 派律师出席并见证公司2024年年度股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 （以下简称"《股东会规则》"）、《律师事务所从事证券法律业务管理办法》 （以下简称"《证券法律业务管理办法》"）、《律师事务所证券法律业务执业 规则（试行）》（以下简称"《证券法律业务执业规则》"）等相关法律、行政 法规、规章、规范性文件及《苏州麦迪斯顿医疗科技股份有限公司章程》（以下 简称"《公司章程》"）的规定，就本次会议的召集与召开程序、召集人资格、 出席会议人员资格、会议表决程序及表决结果等事宜，出具本法律意见书。 对本法律意见书 ...